AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹1.30 Cr | ₹-5.88 Cr | ₹0.65 Cr | ₹-1.97 Cr | ₹-2.64 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹1.30 Cr |
| Mar2025 | ₹-5.88 Cr |
| Mar2024 | ₹0.65 Cr |
| Mar2023 | ₹-1.97 Cr |
| Mar2022 | ₹-2.64 Cr |
How is Net Cash Inflow / Outflow of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.30 Cr | Positive | |
| Mar2025 | ₹-5.88 Cr | Negative | |
| Mar2024 | ₹0.65 Cr | Positive | |
| Mar2023 | ₹-1.97 Cr | Negative | |
| Mar2022 | ₹-2.64 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹292.4 Cr | -3.4% | -15.6% | 12.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -3.4% |
-15.6% |
12.8% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses